An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to coronavirus disease (COVID-19), a global health pandemic causing millions of deaths worldwide. However, the immunopathogenesis of COVID-19, particularly the interaction between SARS-CoV-2 and host innate immunit...
Guardado en:
Autores principales: | Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama-Kohara |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/481e8539bb824e7da5e1c5b29b4caeea |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Activation of Toll-Like Receptors by Live Gram-Negative Bacterial Pathogens Reveals Mitigation of TLR4 Responses and Activation of TLR5 by Flagella
por: Kei Amemiya, et al.
Publicado: (2021) -
Potential value of pharmacological agents acting on toll-like receptor (TLR) 7 and/or TLR8 in COVID-19
por: Amani E. Khalifa, PhD, et al.
Publicado: (2021) -
Toll-Like Receptor 4 and Inflammatory Micro-Environment of Pancreatic Islets in Type-2 Diabetes Mellitus: A Therapeutic Perspective
por: Wang Z, et al.
Publicado: (2020) -
Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection
por: Hi Eun Jung, et al.
Publicado: (2021) -
Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery
por: Kelsey A. Gregg, et al.
Publicado: (2017)